OrbiMed Advisors LLC's Form 4 filing
Adicet Bio, Inc. (ACET) · filed Oct 10, 2025
- Accession no.
- 0000947871-25-000898
- Filed
- Oct 10, 2025, 8:06 PM ET
- Trade date
- Oct 8, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $5.00M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Israel GP Ltd.CIK 0001569590 | 10% Owner |
| OrbiMed Israel BioFund GP Limited PartnershipCIK 0001569821 | 10% Owner |
| OrbiMed Capital GP V LLCCIK 0001615374 | 10% Owner |
| OrbiMed Israel GP II, L.P.CIK 0001682090 | 10% Owner |
| OrbiMed Advisors Israel II LtdCIK 0001682093 | 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | Common Stock | PPurchaseAcquired | +1,500,000 | $1.00 | +$1,500,000 | 9,026,359 | Indirect | |
| Oct 8, 2025 | Common Stock | PPurchaseAcquired | +3,500,000 | $1.00 | +$3,500,000 | 4,490,254 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.